• Corporate and technology positioning for funding and/or acquisitions

  • Structuring and negotiation of partnerships and alliances

  • Market analysis

  • Technology evaluation and due diligence

  • Business plan development/review

  • Product management and support

  • Patent research and analysis

  • Brand and corporate communications

  • Bioprocess and manufacturing


  • Developed strategies that have raised over $120 million USD in corporate financing

  • Repositioned company in antibody space leading to series B and a $500 million USD partnership deal

  • Closed over 35 partnership deals for clients

  • Developed/executed 3 year strategy to take early company to profitability

  • Marketing strategy that led to $12 Million in private financing

  • Developed business strategy for an emerging translational medicine institute

  • Developed IP strategy to allow client a license-free development program in the monoclonal antibody space


"DNA Bridges was very good at bringing in other experts. They were instrumental in getting the opinions of important people about this project and doing the necessary preliminary PR."

- Project leader at biotech start-up

An independent third party conducted a quality survey for DNA Bridges,Inc. The third party, in association with Dunn and Bradstreet, interviewed several clients. All clients stated that the costs met expectations and projects were competed on time.


Corporate Strategy

Bioprocessing and Manufacturing